Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 19 Tumor-Agnostic 2 Gynecologic 2 Sarcoma 1 Plasma cell 1 Other hematologic neoplasm 1 Myeloid 1 Lymphoid 1 Genitourinary 1 Gastrointestinal 1 Dermatologic 1 Classical hematology 1

Conditions

Melanoma 7 Rectal Neoplasms 2 Pancreatic Neoplasms 2 Neoplasms 2 Colonic Neoplasms 2 Breast Neoplasms 2 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Thyroid Neoplasms 1 Testicular Neoplasms 1 Teratoma 1 Stomach Neoplasms 1 Prostatic Neoplasms 1 Ovarian Neoplasms 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Lymphoma 1 Lung Neoplasms 1 Hematologic Neoplasms 1 Glioma 1 Esophageal Neoplasms 1 Endometrial Neoplasms 1 Colorectal Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma, Hepatocellular 1 Breast Neoplasms, Male 1

Interventions

pembrolizumab 36 Cyclophosphamide 24 Nivolumab 23 Ipilimumab 22 aldesleukin 19 Interleukin-2 15 fludarabine 14 Specimen Handling 12 Dacarbazine 11 fludarabine phosphate 10 Magnetic Resonance Spectroscopy 10 Temozolomide 9 Radiosurgery 9 Biopsy 9 cemiplimab 8 Paclitaxel 8 dabrafenib 5 binimetinib 5 Vemurafenib 5 Radiotherapy 5 Carboplatin 5 trametinib 4 sargramostim 4 encorafenib 4 avelumab 4 Pemetrexed 4 Leucovorin 4 Fluorouracil 4 Cisplatin 4 Bevacizumab 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasm Metastasis × palbociclib × Dermatologic × Clear all

NCT04720768 2024-01-05

CELEBRATE

Peter MacCallum Cancer Centre, Australia

Phase 1/2 Unknown

Melanoma, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡